Table 1.

Summary of recent studies assessing final height in pediatric renal transplant recipients

Study	Tx period	Population (n)	rhGH post-Tx (n)	Age at Tx (years)	Follow-up (years)	Height SDSa			Growth determinants
						At Tx	Final Height	Normal heightb
Andre et al. 2003 [5]	1975	19 (11 boys)	0	13.2	10.9	−3.1	−2.6	42%	Height at ESRD; duration and cause of ESRD
Englund et al. 2003 [6]	1981–1994	24 (8 boys)	6	9.5	7.6	−1.7	−1.1	75%	Height at Tx; bone age; graft function
Ninik et al. 2002 [7]	1985–1998	82 (53 boys)	0	10.3	> 5	−2.1 (n = 82)	−1.3 (n = 47)	-	Height at Tx; age at Tx; final GFR; steroid dose
Nissel et al. 2004 [8]	1983–2002	37 (18 boys)	0	10.2 (girls)	8.5	−2.9 (girls)	−1.9 (girls)	68%	Height at Tx; graft function
				12.5 (boys)		−1.7 (boys)	−1.0 (boys)
Offner et al. 1999 [9]	1970–1993	100 (47 boys)	7	13.6	13.1	−2.2	−2.4c	47%c	-
Rodriguez-Soriano et al. 2000 [10]	1986–1999	32 (17 boys)	3	12.1	7.2 (median)	−1.6 (girls)	−1.2 (girls)	69%	Height at Tx and at start of dialysis; duration of dialysis
						−1.4 (boys)	−1.6 (boys)

Tx Transplantation, ESRD end stage renal disease, GFR glomerular filtration rate, SDS standard deviation score, rhGH recombinant human growth hormone

^aHeight values are expressed in SDS compared with local measurements

^bNormal height is defined as a final height > − 2 SDS

^cFinal height in 84 non-cystinotic patients: −1.8 SDS (56% achieved normal height)